Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
inclisiran
life sciences
national blog main
new york blog main
new york top stories
6
×
regeneron pharmaceuticals
boston top stories
national top stories
biotech
cholesterol
clinical trials
new york
pcsk9
praluent
repatha
alirocumab
alnylam pharmaceuticals
evolocumab
medicines co.
pcsk9 inhibitors
san francisco blog main
san francisco top stories
sanofi
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
evercore isi
heart attack
indiana blog main
indiana top stories
ldl
medco
mt sinai hospital
national
prashant vaishnava
raleigh-durham blog main
raleigh-durham top stories
What
cholesterol
6
×
drug
lowering
medco
medicines
new
fda
twice
wave
abbvie’s
aces
acquire
agreed
alnylam
announced
barbecuing
based
big
billion
bio
bringing
brings
camping
cardiologist
cash
center
ceo
check
clears
closer
company
compound
conference
data
day
deal
drugs
evidence
expensive
faces
Language
unset
Current search:
cholesterol
×
" new york top stories "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms